Experimental study on central effects of carboxyethyl-gamma-aminobutyric acid (CEGABA).
P Bo, C Camana, M Curti, F Fussi, A Giorgetti, F Savoldi
Index: Farmaco. Sci. 43(4) , 363-72, (1988)
Full Text: HTML
Abstract
The central effects of carboxyethyl-gamma-aminobutyric acid (CEGABA) have been studied both in rabbits and in the guinea pig myoclonus model. This drug caused EEG synchronization and behavioural sedation both after intravenous (i.v.) and intracerebroventricular (i.c.v.) administration in a dose-dependent manner, in rabbits. CEGABA showed a protective action against myoclonus induced by means of L-5-HTP in young guinea pigs. These data substantiate the hypothesis that CEGABA is a drug active on the central nervous system and probably exerts its action by strengthening cortical inhibition and/or directly acting on lower brainstem.
Related Compounds
Related Articles:
1985-03-18
[J. Immunol. Methods 77 , 229, (1985)]
1987-06-26
[Neurosci. Lett. 77(3) , 308-10, (1987)]
1988-02-15
[Biochem. Biophys. Res. Commun. 150(3) , 931-6, (1988)]
Pharmacological effects of CEGABA, a new aminoacid occurring in mammalian brain.
1987-01-01
[Farmaco. Sci. 42(1) , 77-9, (1987)]